Expert Talk on Tofacitinib: Choosing the right patients – Balancing Safety and Efficacy by Dr. Chandrashekara. S
Grey Areas in Rheumatology – Session:5- Perioperative management of biologics by Dr. Prakruthi Jaladhar
Grey Areas in Rheumatology – Session:3- Seronegative RA: Diagnostic Certainty and Treatment by Dr. Shivaputrappa Ghanti
Grey Areas in Rheumatology – Session 1, Topic: ANA Positive: When should we treat? by Dr. Mukhtar Ahmad Masoodi
Grey Areas in Rheumatology – Session 2, Topic: Positive ANA: When should we investigate further? by Dr. Utkarsha Patil
Live Case Discussion – 2026, Topic: Lupus Nephritis with Incomplete Renal Response by Dr. Sayid Fahad Nizar
Rheumatology Year in Review – 2026, Session-3: EULAR 2023 recommendations for the management of Systemic Lupus Erythematosus (Non-Renal SLE) – Part 1 by Dr. Apurva Khare
Rheumatology Year in Review – 2026, Session-2: Sjögren Disease: From symptomatic treatment to systemic immunomodulation by Dr. Swetha Jayaram
